Key facts
- It has raised $280K.
- Notable investors include Venture Kick, Kickfund, Venture (Switzerland), Gebert Rüf Foundation.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Procavea
- ·The full record, as it builds
Funding rounds
No funding rounds for Procavea are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Procavea
Developer of a proprietary protein cage-based platform for targeted drug delivery designed to streamline and enhance the efficiency of veterinary practice management. The company's platform offers veterinary professionals a robust solution, optimizing practice management and enhancing overall efficiency, enabling customers to elevate their veterinary services through seamless and integrated processes.
- Sector
- Healthcare
- HQ
- Zurich, Switzerland
- Employees
- 3
- Website
- procavea.com/
- Ownership
- Privately Held (backing)
Procavea doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Procavea shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Procavea in its N-PORT filings yet. We sweep new filings monthly.